scispace - formally typeset
B

Beifang Niu

Researcher at Chinese Academy of Sciences

Publications -  73
Citations -  23064

Beifang Niu is an academic researcher from Chinese Academy of Sciences. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 21, co-authored 48 publications receiving 17240 citations. Previous affiliations of Beifang Niu include Washington University in St. Louis & University of California, San Diego.

Papers
More filters
Journal ArticleDOI

Cd-hit

TL;DR: A new CD-HIT program accelerated with a novel parallelization strategy and some other techniques to allow efficient clustering of such datasets to reduce sequence redundancy and improve the performance of other sequence analyses is developed.
Journal ArticleDOI

Comprehensive molecular characterization of gastric adenocarcinoma

Adam J. Bass, +257 more
- 11 Sep 2014 - 
TL;DR: A comprehensive molecular evaluation of 295 primary gastric adenocarcinomas as part of The Cancer Genome Atlas (TCGA) project is described and a molecular classification dividing gastric cancer into four subtypes is proposed.
Journal ArticleDOI

Mutational landscape and significance across 12 major cancer types

TL;DR: Data and analytical results for point mutations and small insertions/deletions from 3,281 tumours across 12 tumour types are presented as part of the TCGA Pan-Cancer effort, and clinical association analysis identifies genes having a significant effect on survival.
Journal ArticleDOI

CD-HIT Suite

TL;DR: A new web server, CD-HIT Suite, is developed for clustering a user-uploaded sequence dataset or comparing it to another dataset at different identity levels and users can now interactively explore the clusters within web browsers.
Journal ArticleDOI

Pan-cancer analysis of whole genomes

Peter J. Campbell, +1332 more
- 06 Feb 2020 - 
TL;DR: The flagship paper of the ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium describes the generation of the integrative analyses of 2,658 whole-cancer genomes and their matching normal tissues across 38 tumour types, the structures for international data sharing and standardized analyses, and the main scientific findings from across the consortium studies.